Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Singh v. Schikan et al
Case Number:
1:14-cv-05450
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
June 11, 2015
Prosensa Investors Urge Redo On Suit Over Failed Drug
Shareholders of Dutch biotech outfit Prosensa Holding NV urged a New York federal judge Thursday to trigger a reconsideration of their securities class action's dismissal in order to "prevent manifest injustice" to those who lost money when the company's stock dropped following a devastating clinical-trial failure.
-
May 06, 2015
Prosensa Beats IPO Investors' Suit Over Failed Drug
A New York federal judge has dismissed a shareholder class action against Dutch biotech company Prosensa Holding NV over a stock drop following a clinical-trial failure for its crown-jewel drug, saying Tuesday the plaintiffs didn't plead that executives omitted necessary information.